Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-21

Clinical Trial Update: Exparel vs Block for ACL Reconstruction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing Exparel with a nerve block for ACL reconstruction is currently enrolling by invitation to evaluate postoperative pain ou…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exparel (liposomal bupivacaine)

Snippet

Sponsor: Rothman Institute Orthopaedics | Conditions: ACL, Postoperative Pain | Phase 4 | Status: ENROLLING_BY_INVITATION